Neurocrine Biosciences
NBIX
#1482
Rank
S$15.56 B
Marketcap
$154.16
Share price
-1.75%
Change (1 day)
-1.40%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) Fails to deliver data

Key failure to deliver metrics for Neurocrine Biosciences :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Neurocrine Biosciences (NBIX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Neurocrine Biosciences (NBIX) - since 2013

Volume in USD (price x number of shares), data since 2013

Neurocrine Biosciences (NBIX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024S$17.86 M-18.47%
2023S$21.91 M-32.24%
2022S$32.34 M-26.75%
2021S$44.16 M193.08%
2020S$15.06 M-65.24%
2019S$43.34 M-3.16%
2018S$44.76 M-18.56%
2017S$54.96 M78.43%
2016S$30.8 M53.41%
2015S$20.07 M66.9%
2014S$12.03 M241.08%
2013S$3.52 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
S$8.53 MS$63.57 M๐Ÿ‡บ๐Ÿ‡ธ USA
S$6.74 MS$12.02 M๐Ÿ‡ฌ๐Ÿ‡ง UK
S$0.22 MS$2.24 M๐Ÿ‡บ๐Ÿ‡ธ USA
S$39.92 MS$0.13 B๐Ÿ‡บ๐Ÿ‡ธ USA
S$77.32 MS$0.11 B๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.24 BS$0.50 B๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.84 MS$2.34 M๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.09 MS$0.71 M๐Ÿ‡บ๐Ÿ‡ธ USA